Pharma, Research Sectors Warn U.K. of 'Catastrophic' No-Deal Brexit
Pharma, Research Sectors Warn U.K. of 'Catastrophic' No-Deal Brexit
GALWAY, IRELAND--March 27, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The U.K.'s pharmaceutical and scientific research sectors have warned the U.K. government that a no-deal Brexit from the European Union (EU) would be catastrophic.
Within this article: Details impact of no-deal Brexit on pharma and research sectors in UK, lower investment, delays with medical supplies, relocation of HQs outside the U.K.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects